173 related articles for article (PubMed ID: 38823454)
1. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.
Carlin S; Cuker A; Gatt A; Gendron N; Hernández-Gea V; Meijer K; Siegal DM; Stanworth S; Lisman T; Roberts LN
J Thromb Haemost; 2024 May; ():. PubMed ID: 38823454
[TBL] [Abstract][Full Text] [Related]
2. Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.
Priyanka P; Kupec JT; Krafft M; Shah NA; Reynolds GJ
Int J Hepatol; 2018; 2018():8432781. PubMed ID: 29973997
[TBL] [Abstract][Full Text] [Related]
3. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
[TBL] [Abstract][Full Text] [Related]
4. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
Ha NB; Regal RE
Ann Pharmacother; 2016 May; 50(5):402-9. PubMed ID: 26861989
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
[TBL] [Abstract][Full Text] [Related]
8. Portal vein thrombosis in cirrhosis.
Raja K; Jacob M; Asthana S
J Clin Exp Hepatol; 2014 Dec; 4(4):320-31. PubMed ID: 25755579
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
[TBL] [Abstract][Full Text] [Related]
10. Portal vein thrombosis.
Chawla YK; Bodh V
J Clin Exp Hepatol; 2015 Mar; 5(1):22-40. PubMed ID: 25941431
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
13. Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review.
Gupta S; Hidalgo J; Singh B; Iyer A; Yang Y; Short A; Singh S; Bhatt H; Gupta S
Cureus; 2021 Aug; 13(8):e16922. PubMed ID: 34367844
[TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.
Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N
Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis.
Primignani M; Tosetti G; La Mura V
World J Hepatol; 2015 Dec; 7(29):2906-12. PubMed ID: 26689354
[TBL] [Abstract][Full Text] [Related]
16. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH.
Roberts LN; Hernandez-Gea V; Magnusson M; Stanworth S; Thachil J; Tripodi A; Lisman T
J Thromb Haemost; 2022 Oct; 20(10):2237-2245. PubMed ID: 35948998
[TBL] [Abstract][Full Text] [Related]
17. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.
Rugivarodom M; Charatcharoenwitthaya P
J Clin Transl Hepatol; 2020 Dec; 8(4):432-444. PubMed ID: 33447527
[TBL] [Abstract][Full Text] [Related]
18. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis.
Ng CH; Tan DJH; Nistala KRY; Syn N; Xiao J; Tan EXX; Woo FZ; Chew NWS; Huang DQ; Dan YY; Sanyal AJ; Muthiah MD
Hepatol Int; 2021 Oct; 15(5):1196-1206. PubMed ID: 34417718
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for people with cancer and central venous catheters.
Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
[TBL] [Abstract][Full Text] [Related]
20. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
